| EPE367 | The Global HIV Prevention Coalition (GPC) scorecards: a framework for analyzing progress and performance of national HIV prevention responses | E-poster | Approaches to using data to improve programming |
| PEMOE34 | Case-finding, linkage to antiretroviral treatment (ART), and continuity of care: findings from 'Siyenza' facilities in South Africa, 2019-2021 | Poster exhibition | Approaches to using data to improve programming |
| EPE118 | Enhanced adherence counselling (EAC) enrollment via phone: a strategy to improve timeliness of enrollment and completion of EAC among HIV-infected patients with high viral load at Nkwen Baptist Hospital, Cameroon | E-poster | Approaches to viral load monitoring at scale |
| EPE119 | Applying a seven-step approach to rapidly improve viral load testing coverage: lessons from Burundi, Nigeria and Togo | E-poster | Approaches to viral load monitoring at scale |
| EPE120 | HIV drug resistance testing gap in Malawi's HIV programme advocates for increased local genotyping capacity | E-poster | Approaches to viral load monitoring at scale |
| EPE121 | Comparison of phone based and in-person adherence counseling for non suppressed PLHIV on anti retroviral therapy (ART) in military facilities in Uganda.''''' | E-poster | Approaches to viral load monitoring at scale |
| EPE122 | Promising association between caregiver and pediatric viral load outcomes. Key Interventions to Develop Systems and Services (KIDSS) - Orphans and Vulnerable Children Project - Cameroon | E-poster | Approaches to viral load monitoring at scale |
| EPLBE10 | Expanding viral load coverage in the pursuit of HIV epidemic control in Lualaba province in the Democratic Republic of Congo | E-poster | Approaches to viral load monitoring at scale |
| EPB146 | Cost-effective continuous flow synthesis of HIV second and third generation integrase inhibitor drugs: a step towards local API manufacturing in Africa | E-poster | ART in acute, first- and second-line therapies |
| EPB147 | Treatment experience of single-tablet dolutegravir/lamivudine in the United States: results from the 'real-world outcomes with dolutegravir-based two-drug-regimens for the treatment of HIV-1' (TANDEM study) | E-poster | ART in acute, first- and second-line therapies |